Global Encorafenib Market Growth 2022-2028
- LP 4768494
- 79 Pages
- January 2022
- Pharmaceuticals
The United States Encorafenib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Encorafenib market, reaching US$ million by the year 2028. As for the Europe Encorafenib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Encorafenib players cover Array BioPharma, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Encorafenib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
50mg Capsules
75mg Capsules
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Pharmacy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Array BioPharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Encorafenib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Encorafenib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Encorafenib by Country/Region, 2017, 2022 & 2028
2.2 Encorafenib Segment by Type
2.2.1 50mg Capsules
2.2.2 75mg Capsules
2.3 Encorafenib Sales by Type
2.3.1 Global Encorafenib Sales Market Share by Type (2017-2022)
2.3.2 Global Encorafenib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Encorafenib Sale Price by Type (2017-2022)
2.4 Encorafenib Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.4.4 Other
2.5 Encorafenib Sales by Application
2.5.1 Global Encorafenib Sale Market Share by Application (2017-2022)
2.5.2 Global Encorafenib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Encorafenib Sale Price by Application (2017-2022)
3 Global Encorafenib by Company
3.1 Global Encorafenib Breakdown Data by Company
3.1.1 Global Encorafenib Annual Sales by Company (2020-2022)
3.1.2 Global Encorafenib Sales Market Share by Company (2020-2022)
3.2 Global Encorafenib Annual Revenue by Company (2020-2022)
3.2.1 Global Encorafenib Revenue by Company (2020-2022)
3.2.2 Global Encorafenib Revenue Market Share by Company (2020-2022)
3.3 Global Encorafenib Sale Price by Company
3.4 Key Manufacturers Encorafenib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Encorafenib Product Location Distribution
3.4.2 Players Encorafenib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Encorafenib by Geographic Region
4.1 World Historic Encorafenib Market Size by Geographic Region (2017-2022)
4.1.1 Global Encorafenib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Encorafenib Annual Revenue by Geographic Region
4.2 World Historic Encorafenib Market Size by Country/Region (2017-2022)
4.2.1 Global Encorafenib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Encorafenib Annual Revenue by Country/Region
4.3 Americas Encorafenib Sales Growth
4.4 APAC Encorafenib Sales Growth
4.5 Europe Encorafenib Sales Growth
4.6 Middle East & Africa Encorafenib Sales Growth
5 Americas
5.1 Americas Encorafenib Sales by Country
5.1.1 Americas Encorafenib Sales by Country (2017-2022)
5.1.2 Americas Encorafenib Revenue by Country (2017-2022)
5.2 Americas Encorafenib Sales by Type
5.3 Americas Encorafenib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Encorafenib Sales by Region
6.1.1 APAC Encorafenib Sales by Region (2017-2022)
6.1.2 APAC Encorafenib Revenue by Region (2017-2022)
6.2 APAC Encorafenib Sales by Type
6.3 APAC Encorafenib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Encorafenib by Country
7.1.1 Europe Encorafenib Sales by Country (2017-2022)
7.1.2 Europe Encorafenib Revenue by Country (2017-2022)
7.2 Europe Encorafenib Sales by Type
7.3 Europe Encorafenib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Encorafenib by Country
8.1.1 Middle East & Africa Encorafenib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Encorafenib Revenue by Country (2017-2022)
8.2 Middle East & Africa Encorafenib Sales by Type
8.3 Middle East & Africa Encorafenib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Encorafenib
10.3 Manufacturing Process Analysis of Encorafenib
10.4 Industry Chain Structure of Encorafenib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Encorafenib Distributors
11.3 Encorafenib Customer
12 World Forecast Review for Encorafenib by Geographic Region
12.1 Global Encorafenib Market Size Forecast by Region
12.1.1 Global Encorafenib Forecast by Region (2023-2028)
12.1.2 Global Encorafenib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Encorafenib Forecast by Type
12.7 Global Encorafenib Forecast by Application
13 Key Players Analysis
13.1 Array BioPharma
13.1.1 Array BioPharma Company Information
13.1.2 Array BioPharma Encorafenib Product Offered
13.1.3 Array BioPharma Encorafenib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Array BioPharma Main Business Overview
13.1.5 Array BioPharma Latest Developments
14 Research Findings and Conclusion
Table 1. Encorafenib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Encorafenib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 50mg Capsules
Table 4. Major Players of 75mg Capsules
Table 5. Global Encorafenib Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Encorafenib Sales Market Share by Type (2017-2022)
Table 7. Global Encorafenib Revenue by Type (2017-2022) & ($ million)
Table 8. Global Encorafenib Revenue Market Share by Type (2017-2022)
Table 9. Global Encorafenib Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Encorafenib Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Encorafenib Sales Market Share by Application (2017-2022)
Table 12. Global Encorafenib Revenue by Application (2017-2022)
Table 13. Global Encorafenib Revenue Market Share by Application (2017-2022)
Table 14. Global Encorafenib Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Encorafenib Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Encorafenib Sales Market Share by Company (2020-2022)
Table 17. Global Encorafenib Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Encorafenib Revenue Market Share by Company (2020-2022)
Table 19. Global Encorafenib Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Encorafenib Producing Area Distribution and Sales Area
Table 21. Players Encorafenib Products Offered
Table 22. Encorafenib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Encorafenib Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Encorafenib Sales Market Share Geographic Region (2017-2022)
Table 27. Global Encorafenib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Encorafenib Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Encorafenib Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Encorafenib Sales Market Share by Country/Region (2017-2022)
Table 31. Global Encorafenib Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Encorafenib Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Encorafenib Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Encorafenib Sales Market Share by Country (2017-2022)
Table 35. Americas Encorafenib Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Encorafenib Revenue Market Share by Country (2017-2022)
Table 37. Americas Encorafenib Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Encorafenib Sales Market Share by Type (2017-2022)
Table 39. Americas Encorafenib Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Encorafenib Sales Market Share by Application (2017-2022)
Table 41. APAC Encorafenib Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Encorafenib Sales Market Share by Region (2017-2022)
Table 43. APAC Encorafenib Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Encorafenib Revenue Market Share by Region (2017-2022)
Table 45. APAC Encorafenib Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Encorafenib Sales Market Share by Type (2017-2022)
Table 47. APAC Encorafenib Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Encorafenib Sales Market Share by Application (2017-2022)
Table 49. Europe Encorafenib Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Encorafenib Sales Market Share by Country (2017-2022)
Table 51. Europe Encorafenib Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Encorafenib Revenue Market Share by Country (2017-2022)
Table 53. Europe Encorafenib Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Encorafenib Sales Market Share by Type (2017-2022)
Table 55. Europe Encorafenib Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Encorafenib Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Encorafenib Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Encorafenib Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Encorafenib Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Encorafenib Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Encorafenib Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Encorafenib Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Encorafenib Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Encorafenib Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Encorafenib
Table 66. Key Market Challenges & Risks of Encorafenib
Table 67. Key Industry Trends of Encorafenib
Table 68. Encorafenib Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Encorafenib Distributors List
Table 71. Encorafenib Customer List
Table 72. Global Encorafenib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Encorafenib Sales Market Forecast by Region
Table 74. Global Encorafenib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Encorafenib Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Encorafenib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Encorafenib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Encorafenib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Encorafenib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Encorafenib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Encorafenib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Encorafenib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Encorafenib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Encorafenib Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Encorafenib Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Encorafenib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Encorafenib Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Encorafenib Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Encorafenib Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Encorafenib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Encorafenib Revenue Market Share Forecast by Application (2023-2028)
Table 92. Array BioPharma Basic Information, Encorafenib Manufacturing Base, Sales Area and Its Competitors
Table 93. Array BioPharma Encorafenib Product Offered
Table 94. Array BioPharma Encorafenib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Array BioPharma Main Business
Table 96. Array BioPharma Latest Developments
List of Figures
Figure 1. Picture of Encorafenib
Figure 2. Encorafenib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Encorafenib Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Encorafenib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Encorafenib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 50mg Capsules
Figure 10. Product Picture of 75mg Capsules
Figure 11. Global Encorafenib Sales Market Share by Type in 2021
Figure 12. Global Encorafenib Revenue Market Share by Type (2017-2022)
Figure 13. Encorafenib Consumed in Hospital
Figure 14. Global Encorafenib Market: Hospital (2017-2022) & (K Pcs)
Figure 15. Encorafenib Consumed in Clinic
Figure 16. Global Encorafenib Market: Clinic (2017-2022) & (K Pcs)
Figure 17. Encorafenib Consumed in Pharmacy
Figure 18. Global Encorafenib Market: Pharmacy (2017-2022) & (K Pcs)
Figure 19. Encorafenib Consumed in Other
Figure 20. Global Encorafenib Market: Other (2017-2022) & (K Pcs)
Figure 21. Global Encorafenib Sales Market Share by Application (2017-2022)
Figure 22. Global Encorafenib Revenue Market Share by Application in 2021
Figure 23. Encorafenib Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Encorafenib Revenue Market Share by Company in 2021
Figure 25. Global Encorafenib Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Encorafenib Revenue Market Share by Geographic Region in 2021
Figure 27. Global Encorafenib Sales Market Share by Region (2017-2022)
Figure 28. Global Encorafenib Revenue Market Share by Country/Region in 2021
Figure 29. Americas Encorafenib Sales 2017-2022 (K Pcs)
Figure 30. Americas Encorafenib Revenue 2017-2022 ($ Millions)
Figure 31. APAC Encorafenib Sales 2017-2022 (K Pcs)
Figure 32. APAC Encorafenib Revenue 2017-2022 ($ Millions)
Figure 33. Europe Encorafenib Sales 2017-2022 (K Pcs)
Figure 34. Europe Encorafenib Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Encorafenib Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Encorafenib Revenue 2017-2022 ($ Millions)
Figure 37. Americas Encorafenib Sales Market Share by Country in 2021
Figure 38. Americas Encorafenib Revenue Market Share by Country in 2021
Figure 39. United States Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Encorafenib Sales Market Share by Region in 2021
Figure 44. APAC Encorafenib Revenue Market Share by Regions in 2021
Figure 45. China Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Encorafenib Sales Market Share by Country in 2021
Figure 52. Europe Encorafenib Revenue Market Share by Country in 2021
Figure 53. Germany Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Encorafenib Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Encorafenib Revenue Market Share by Country in 2021
Figure 60. Egypt Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Encorafenib Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Encorafenib in 2021
Figure 66. Manufacturing Process Analysis of Encorafenib
Figure 67. Industry Chain Structure of Encorafenib
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
